https://padlet.com/himalayabutta21/hct71vj3n7dyg55f Global Deal: Novartis & The Medicine Co. Indian Deal: Infosys & Simplus en-us 2020-08-04 13:39:37 UTC 2024-10-15 05:38:24 UTC hello@padlet.com https://padlet.net/icons/png/1f91d.png himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669307628 Recently in January 2020 Novartis a Swiss multinational Pharmaceutical company completely acquired The Medicine Company a  biopharmaceutical company based in United States for a whopping amount of $9.7B. This acquisition can be termed as horizontal acquisition since they are competing in the same market and in order to acquire market share and to earn a competitive edge Novartis acquire the target company.]]> 2020-08-04 17:46:31 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669307628 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669313394 As soon as Novartis bought the company at a price of $85 per share which was above than the actual price i.e. $68.55 per share the share price of medicine company shoot up to $84 per share which depicts that the investor sentiments are aligned with the deal. Whereas share price of Novartis i.e. the acquirer also went up because of this deal which is an abnormal return for the company, since during such deals the acquirer's stakeholders/investors might feel such acquisition as expenses but here the share price touches $92.3 per share within 2 days of the deal completion, which represents that the investors sentiments are aligned with the deals and definitely provides good returns.]]> 2020-08-04 17:52:08 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669313394 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669320971 The Novartis company goes with the behavioural class of thought as they focused on the future perspectives of this acquisitions since the Medicines Company and inclisiran gives Novartis a unique opportunity to open up a new chapter on the treatment of the world’s leading cause of mortality and disability with a vaccine-like approach. What else make this deal more strategic for the company was last year the Medicines Company presented data at the American Heart Association’s annual meeting from the Phase III ORION-9 and ORION-10 studies of inclisiran, respectively testing the drug in patients with heterozygous familial hypercholesterolemia (HeFH) and atherosclerotic cardiovascular disease (ASCVD) which makes it more attractive and useful for the Novartis company by considering the future aspects for the company's growth and market share.]]> 2020-08-04 17:59:25 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669320971 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669323639 On 13th March 2020, the IT service giant of India Infosys based in Bengaluru, India closed a strategic deal of $250M  by completely acquiring Simplus a platinum salesforce partnered company based in Salt Lake, Utah. This acquisition can be termed as vertical acquisition since the target company provides support to the acquirer company through software support or services. ]]> 2020-08-04 18:02:04 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669323639 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669327954 After analysing the deal, it represents the neo-classical approach of the acquirer as Infosys’s is making inorganic push toward enhancing capabilities in the Sales force ecosystem. This acquisition was for the reconfiguration of resources aiming to improve the efficiency in response to the economic and technological innovations as "Simplus brings to Infosys globally recognized Salesforce expertise, industry knowledge, solution assets, deep ecosystem relationships and a broad clientele, across a variety of industries including high-tech, financial services, retail, healthcare, life sciences and manufacturing". It has offices across North America, Sydney, Melbourne, London, and a large delivery centre in Manila, which provide reach to other regions as well. ]]> 2020-08-04 18:06:12 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669327954 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669329878 Since, the acquisition is not very large. The acquisition was valued at 3.7x enterprise value-to-sales FY20, a bit on the. Simplus has a revenue base of $67M in FY20, growing at ~60 percent year-on-year. Assuming 45 percent year-on-year growth in FY21E, this acquisition accounts to 0.7 percent of Infosys. Although the acquisition is strategically for the enhancement of their salesforce operations but along with that the acquisition also helped in expanding their reach to other geographical locations which indirectly benefit the company which can be seen as the increment in the stock price just after the announcement of the deal.  ]]> 2020-08-04 18:08:07 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669329878 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669334821 2020-08-04 18:13:06 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669334821 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669335834 February news]]> 2020-08-04 18:14:19 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669335834 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669337882 November News]]> 2020-08-04 18:16:32 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669337882 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669340390 2020-08-04 18:18:43 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669340390 himalayabutta21 https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669342065 2020-08-04 18:20:28 UTC https://padlet.com/himalayabutta21/hct71vj3n7dyg55f/wish/669342065